LDL-LDL receptor interaction and LDL clearance has been demonstrated to be a fundamental pathway of RCT39 indicating that independently of the increase in HDL mediated CEC RCT in FH patients remains defective due to LDL receptor dysfunction. Here, LDLR is linked to familial hyperaldosteronism.